BR0112897A - Associação que tem uma sinergia de ação, composições farmacêuticas injetáveis, kit de apresentação - Google Patents

Associação que tem uma sinergia de ação, composições farmacêuticas injetáveis, kit de apresentação

Info

Publication number
BR0112897A
BR0112897A BR0112897-3A BR0112897A BR0112897A BR 0112897 A BR0112897 A BR 0112897A BR 0112897 A BR0112897 A BR 0112897A BR 0112897 A BR0112897 A BR 0112897A
Authority
BR
Brazil
Prior art keywords
synergy
action
association
pharmaceutical compositions
injectable pharmaceutical
Prior art date
Application number
BR0112897-3A
Other languages
English (en)
Inventor
Celine Feger
Philippe Moreillon
Jacques Vouillamoz
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0112897A publication Critical patent/BR0112897A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thyristors (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"ASSOCIAçãO QUE TEM UMA SINERGIA DE AçãO, COMPOSIçõES FARMACêUTICAS INJETáVEIS, E, KIT DE APRESENTAçãO". Associações que têm uma sinergia de ação caracterizadas pelo fato de que elas consistem de uma combinação de quinupristina/dalfopristina com cefpiroma, assim como as composições e os kits de apresentação relativos às mesmas.
BR0112897-3A 2000-08-03 2001-08-02 Associação que tem uma sinergia de ação, composições farmacêuticas injetáveis, kit de apresentação BR0112897A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010245A FR2812549B1 (fr) 2000-08-03 2000-08-03 Associations dalfopristine/quinupristine avec le cefpirome
PCT/FR2001/002520 WO2002011751A2 (fr) 2000-08-03 2001-08-02 Associations dalfopristine/quinupristine avec le cefpirome

Publications (1)

Publication Number Publication Date
BR0112897A true BR0112897A (pt) 2003-06-10

Family

ID=8853264

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112897-3A BR0112897A (pt) 2000-08-03 2001-08-02 Associação que tem uma sinergia de ação, composições farmacêuticas injetáveis, kit de apresentação

Country Status (29)

Country Link
US (2) US7005416B2 (pt)
EP (1) EP1313500B1 (pt)
JP (1) JP2004505926A (pt)
KR (1) KR100808715B1 (pt)
CN (1) CN1256982C (pt)
AR (1) AR033992A1 (pt)
AT (1) ATE279204T1 (pt)
AU (2) AU8409501A (pt)
BR (1) BR0112897A (pt)
CA (1) CA2418023A1 (pt)
CZ (1) CZ2003290A3 (pt)
DE (1) DE60106463T2 (pt)
DK (1) DK1313500T3 (pt)
EA (1) EA007713B1 (pt)
ES (1) ES2230358T3 (pt)
FR (1) FR2812549B1 (pt)
HK (1) HK1058305A1 (pt)
HU (1) HU227455B1 (pt)
IL (1) IL154237A0 (pt)
MX (1) MXPA03000959A (pt)
NO (1) NO20030483D0 (pt)
NZ (1) NZ523982A (pt)
PE (1) PE20020264A1 (pt)
PL (1) PL204278B1 (pt)
PT (1) PT1313500E (pt)
SK (1) SK1202003A3 (pt)
TN (1) TNSN01116A1 (pt)
WO (1) WO2002011751A2 (pt)
ZA (1) ZA200300903B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107420042B (zh) * 2017-09-25 2023-03-31 中国地质大学（武汉） 一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867676A (ja) * 1994-03-30 1996-03-12 Eisai Kagaku Kk 保護アミノチアゾリル酢酸誘導体
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) * 1995-08-04 1997-11-11 Syphar Laboratories, Inc. Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) * 1999-08-27 2002-10-15 Aventis Pharma S.A. Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

Also Published As

Publication number Publication date
JP2004505926A (ja) 2004-02-26
HU227455B1 (en) 2011-06-28
KR20030022351A (ko) 2003-03-15
PE20020264A1 (es) 2002-05-20
ZA200300903B (en) 2003-11-10
NO20030483L (no) 2003-01-30
DE60106463D1 (de) 2004-11-18
EP1313500B1 (fr) 2004-10-13
MXPA03000959A (es) 2003-06-09
CN1256982C (zh) 2006-05-24
EA007713B1 (ru) 2006-12-29
ATE279204T1 (de) 2004-10-15
NZ523982A (en) 2004-10-29
DK1313500T3 (da) 2005-02-14
HUP0300682A3 (en) 2004-09-28
FR2812549B1 (fr) 2003-03-21
HUP0300682A2 (hu) 2003-08-28
IL154237A0 (en) 2003-07-31
NO20030483D0 (no) 2003-01-30
US7005416B2 (en) 2006-02-28
SK1202003A3 (en) 2003-07-01
AU2001284095B2 (en) 2007-04-05
KR100808715B1 (ko) 2008-02-29
AU8409501A (en) 2002-02-18
CN1449290A (zh) 2003-10-15
US20060122103A1 (en) 2006-06-08
TNSN01116A1 (fr) 2005-11-10
PT1313500E (pt) 2005-02-28
FR2812549A1 (fr) 2002-02-08
PL365075A1 (en) 2004-12-27
PL204278B1 (pl) 2009-12-31
WO2002011751A2 (fr) 2002-02-14
ES2230358T3 (es) 2005-05-01
CA2418023A1 (fr) 2002-02-14
EA200300214A1 (ru) 2003-06-26
EP1313500A2 (fr) 2003-05-28
US20020037890A1 (en) 2002-03-28
AR033992A1 (es) 2004-01-21
WO2002011751A3 (fr) 2002-06-13
CZ2003290A3 (cs) 2003-05-14
DE60106463T2 (de) 2005-10-13
HK1058305A1 (en) 2004-05-14

Similar Documents

Publication Publication Date Title
BRPI0411528A (pt) uso de isomalte como prebiótico
BR9811955A (pt) Composição biocida sinergìstica
BRPI0512878A (pt) formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
BR0010113A (pt) Preparações para uso externo na pele
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
SV2002000343A (es) Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
AR059445A1 (es) Composiciones de antimicoticos ramnolipidicos y metodos de uso relacionados
PA8684501A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
BR0211972A (pt) Composição oftálmica
ATE370770T1 (de) Hautreinigungsmittel
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
GT200500340A (es) Derivados de octahidropirrolo [3,4-c] pirrol
PA8582201A1 (es) Indoles 2,7-sustituidos
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
HN2002000235A (es) Formulaciones en combinacion de derivados de 1, 4 - benzotiepina - 1, 1 - dioxido con otras sustancias activas, y su utilización
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
BR0112897A (pt) Associação que tem uma sinergia de ação, composições farmacêuticas injetáveis, kit de apresentação
ES2174297T3 (es) Nuevos derivados de piranosidos.
BR0108562A (pt) Composições endoparasiticidas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: KING PHARMACEUTICALS, INC. (US)

Free format text: TRANSFERIDO DE: AVENTIS PHARMA S.A.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2021 DE 29/09/2009.